Stryker Corporation (SYK)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Kevin A. Lobo | Chairman, CEO & President | 5.7M | 33.71M | 1965 |
| Mr. Glenn S. Boehnlein | VP & CFO | 2.27M | 5.44M | 1962 |
| Mr. Viju S. Menon | Group President of Global Quality & Operations | 1.68M | -- | 1968 |
| Mr. J. Andrew Pierce | Group President of MedSurg & Neurotechnology | 2.03M | 2.69M | 1974 |
| Mr. Spencer S. Stiles | Group President of Orthopaedics & Spine | 2.02M | 2.33M | 1977 |
| Mr. William E. Berry Jr. | VP & Chief Accounting Officer | -- | -- | 1966 |
| Mr. Robert C. Cohen | CTO and VP of Global R&D - Joint Replacement | -- | -- | -- |
| Mr. Alan Douville | VP, Chief Information Officer & Chief Information Security Officer | -- | -- | -- |
| Mr. Robert S. Fletcher | VP & Chief Legal Officer | 895.89k | -- | 1971 |
| Ms. Dana S. McMahon | VP & Chief Compliance Officer | -- | -- | -- |
Stryker Corporation
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 52,000
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Corporate Governance
Recent Events
- Mar 27, 2024Ex-Dividend Date
- Mar 26, 2024DEF 14A: Proxy StatementsSee Full Filing
- Feb 14, 202410-K: Periodic Financial ReportsSee Full Filing
- Jan 30, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Jan 29, 2024SC 13G/A: Tender Offer/Acquisition ReportsSee Full Filing
Upcoming Events
Apr 30, 2024
Dividend Date